Webcast link to Third Quarter 2024 Financial Results Conference Call – Friday, November 15, 2024 at 8:30 a.m. ET

SEC ARS: Annual Report 2023

BPTH_20241024_ARS

SEC Form DEFA-14A: Additional Proxy Materials

BPTH_20241025_DEFA14A

SEC DEF-14A: Proxy Statement

BPTH_20241025_DEF_14A

SEC Form 424b3 Prospectus – October 23, 2024

BPTH._424B3_20241023

SEC Form 14A: Preliminary Proxy Statement

Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

BPTH-20241010_PIPE_Closing

SEC Form 8-K: Press Release dated October 10, 2024

BPTH_20241010_8-K_EDGAR

Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of Obesity

BP1001-A_Obesity_Program_Release

Bio-Path Holdings Announces Publication in Biomedicines

BPTH_Biomedicines_Publication_Release